Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
When an elderly boater falls into shallow water, an emergency medical attendant leaves the boat and goes to work.
Read Full NewsMichael Wechsler, MD, reports 59% of patients in clinical remission with twice-yearly depemokimab at year 1 maintained it at year 2 in SWIFT/AGILE.
Experts Discuss PAH Treatment Selection and Access
HCPLive Five at CHEST 2026
Kim Henriksen, PhD, discusses research evaluating blood-based biomarkers of blood-brain barrier remodeling and immune cell activity in multiple sclerosis, including their potential to track treatment responses and inform future biomarker development.
Brian Snelling, MD, director of the stroke program at Marcus Neuroscience Institute discussed delays in calling 911 after stroke onset, gaps in awareness of atypical symptoms, and how to reach underserved populations.
The clinical professor of neurology and pediatrics at The Ohio State University Wexner Medical Center discussed payer step therapy, earlier preventive treatment, and questions the updated guideline leaves open.
Shadi Yaghi, MD, FAHA, Chair of Neurology at Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, discusses a new calculator that predicts stroke risk within 30 days of a procedure.
1.
A new device enhances liquid biopsy.
2.
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP
3.
PSA Screening May Modestly Curb Prostate Cancer Deaths
4.
ASTRO: American Society for Radiation Oncology
5.
Additional imaging techniques can detect early stage cancers missed by mammograms in women with dense breasts
1.
Molecular Residual Disease Profiles in Cancer: Clinical Implications and Emerging Paradigms
2.
Strategic Breakthroughs in Oncology in Clinical Decision-Making
3.
Preventing Transfusion-Associated Iron Accumulation
4.
The Power of White Blood Cells: How They Help Keep Us Healthy
5.
Targeted Degraders for Lymphoma: Mechanisms, Clinical Implications, and Emerging Therapies
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
Current Scenario of Blood Cancer- Genomic Testing & Advancement in Diagnosis and Treatment
4.
Should We Use DARA Up Front As First-Line Therapy in MM?
5.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge